Sartorius expands manufacturing capacities in China and the UK
The expansions will enable the company's local customers to test equipment directly at the manufacturing site
In the last week, Sartorius has been making good on its plans to invest €400 million in expanding its manufacturing capacities around the world to meet high demand from the growing biopharmaceuticals market.
The company has opened a new customer interaction center (CIC) in the Shunyo District, Beijing, marking the completion of the first phase of expanding the existing production facility.
The additional 7,500 sq. ft of space will enable the company's Chinese customers to test, validate and adjust the functionalities of upstream (for example, bioreactors) and downstream (for example, tangential flow filtration systems) equipment, prior to installation at their factories.
Previously, these customers had to travel to Germany or India to run factory acceptance tests (FATs).
"China is already one of the biggest markets for Sartorius and will become even more important in the next years," said Edison Zhu, Head of Operations BPS Systems China at Sartorius.
This news comes hot on the heels of the company's announcement on Friday that it is expanding in the UK by relocating to a new facility for downstream processing equipment.
The new 58,000-sq. ft Havant site will increase, simplify and accelerate the company's capacity to produce customised equipment that supports downstream processing. It will house engineers with biochemical, electrical and mechanical backgrounds who will design and manufacture a range of systems that are crucial for manufacturing injectable drugs used to treat cancer and diabetes and for producing vaccines to prevent the spread of viruses, for example, chromatography columns and time- and cost-saving tangential flow filtration systems.
Similar to the new CIC in China, the new UK facility offers a dedicated customer test lab to demonstrate the functionality of Sartorius equipment.
These expansions are in line with the company's plans to invest in excess of €400 million in expanding capacities around the world during 2021.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance